AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
133.49B
FIGSX
Price
$20.03
Change
+$0.09 (+0.45%)
Updated
Sep 5 closing price
Net Assets
15.75B
Interact to see
Advertisement

AEPCX vs FIGSX

Header iconAEPCX vs FIGSX Comparison
Open Charts AEPCX vs FIGSXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets133.49B
Fidelity Series International Growth
Price$20.03
Change+$0.09 (+0.45%)
VolumeN/A
Net Assets15.75B
AEPCX vs FIGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FIGSX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FIGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FIGSX (15.7B). FIGSX pays higher dividends than AEPCX: FIGSX (1.36) vs AEPCX (0.16). AEPCX was incepted earlier than FIGSX: AEPCX (25 years) vs FIGSX (16 years). AEPCX (1.57) is less costly to investors than FIGSX (0.01). AEPCX is a more actively managed with annual turnover of: 35.00 vs. FIGSX (26.00). FIGSX has a lower initial minimum investment than AEPCX: FIGSX (0) vs AEPCX (250). FIGSX annual gain was more profitable for investors over the last year : 9.59 vs. AEPCX (7.59). FIGSX return over 5 years is better than : 15.32 vs. AEPCX (7.78).
AEPCXFIGSXAEPCX / FIGSX
Total Expense Ratio1.570.0115,700%
Annual Report Gross Expense Ratio1.570.0115,700%
Fund Existence25 years16 years-
Gain YTD15.03814.917101%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B15.7B847%
Annual Yield % from dividends0.161.3612%
Returns for 1 year7.599.5979%
Returns for 3 years32.6549.7566%
Returns for 5 years7.7815.3251%
Returns for 10 years34.3461.7456%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.